Abstract
Background: Phyllodes tumours are rare fibroepithelial lesions that account for less than 1% of all breast neoplasm. However, phyllodes tumours arising from ectopic breast tissue are even rarer, with less than 15 cases ever reported involving the axilla, vulva and groin.
Case Presentation: A 27-year-old lady presented to the surgical clinic with left axillary swelling, measuring 5cm x 6cm. Ultrasound of the axilla revealed heterogenous mass displacing the left axillary artery and vein medially. Excision was performed, and histopathological examination confirmed the diagnosis of a benign phyllodes tumour.
Conclusion: Phyllodes tumour in ectopic breast tissue over the axilla is a rare occurrence, and our case is the fourth case ever reported. Despite its rarity, diagnosis and treatment modalities are similar to phyllodes tumour of the breast. Regular follow-up is recommended owing to the risk of local recurrence.
Keywords: Phyllodes, Tumour, Ectopic, Axilla, Breast, Mammary.
New Emirates Medical Journal
Title:Axillary Mass Turned Out to be A Phyllodes Tumour in An Ectopic Breast Tissue– A Rare Case Report
Volume: 2 Issue: 2
Author(s): Mohd Shafiq Rahman*Norly Salleh
Affiliation:
- Department of Surgery, Hospital Segamat, KM 6, Jalan Genuang, 85000 Segamat, Johor,Malaysia
Keywords: Phyllodes, Tumour, Ectopic, Axilla, Breast, Mammary.
Abstract: Background: Phyllodes tumours are rare fibroepithelial lesions that account for less than 1% of all breast neoplasm. However, phyllodes tumours arising from ectopic breast tissue are even rarer, with less than 15 cases ever reported involving the axilla, vulva and groin.
Case Presentation: A 27-year-old lady presented to the surgical clinic with left axillary swelling, measuring 5cm x 6cm. Ultrasound of the axilla revealed heterogenous mass displacing the left axillary artery and vein medially. Excision was performed, and histopathological examination confirmed the diagnosis of a benign phyllodes tumour.
Conclusion: Phyllodes tumour in ectopic breast tissue over the axilla is a rare occurrence, and our case is the fourth case ever reported. Despite its rarity, diagnosis and treatment modalities are similar to phyllodes tumour of the breast. Regular follow-up is recommended owing to the risk of local recurrence.
Export Options
About this article
Cite this article as:
Rahman Shafiq Mohd *, Salleh Norly , Axillary Mass Turned Out to be A Phyllodes Tumour in An Ectopic Breast Tissue– A Rare Case Report, New Emirates Medical Journal 2021; 2 (2) . https://dx.doi.org/10.2174/0250688202666210624165530
DOI https://dx.doi.org/10.2174/0250688202666210624165530 |
Print ISSN 0250-6882 |
Publisher Name Bentham Science Publisher |
Online ISSN 0250-6882 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Anticancer Agents Derived from Natural Cinnamic Acids
Anti-Cancer Agents in Medicinal Chemistry NO to Breast: When, Why and Why Not?
Current Pharmaceutical Design Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Role of Progesterone in Human Astrocytomas Growth
Current Topics in Medicinal Chemistry EGFR Inhibitors and Radiation in HNSCC
Current Cancer Therapy Reviews The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer
Current Signal Transduction Therapy Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Islet Amyloid Polypeptide and Diabetes
Current Protein & Peptide Science Peptides in Melanoma Therapy
Current Pharmaceutical Design NF-κB Signaling and Carcinogenesis
Current Pharmaceutical Design Risk Factors for Postembolization Syndrome After Transcatheter Arterial Chemoembolization
Current Medical Imaging Overview of Angiogenesis and the use of Bevacizumab in Patients with Malignant Gliomas
Current Signal Transduction Therapy The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration
Current Cancer Drug Targets Immunotherapeutic and Immunoregulatory Drugs in Haematologic Malignancies
Current Topics in Medicinal Chemistry Development of PET Probes for Cancer Imaging
Current Topics in Medicinal Chemistry Cytostatic Properties of Some Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type I Receptor Antagonists
Current Pharmaceutical Design Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Current Gene Therapy Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Current Cancer Therapy Reviews Biomarkers of Osteoarthritis: A Review of Recent Research Progress on Soluble Biochemical Markers, Published Patents and Areas for Future Development
Recent Patents on Biomarkers